Transcription of Annex 2 WHO good practices for pharmaceutical …
{{id}} {{{paragraph}}}
69 World Health OrganizationWHO Technical Report Series, No. 961, 2011 Annex 2 WHO good practices for pharmaceutical microbiology laboratoriesBackgroundThe WHO Expert Committee on Specifi cations for pharmaceutical Preparations adopted in 2009 a revised version of the good practices for pharmaceutical quality control laboratories (1).During the inspections carried out when prequalifying laboratories , the inspectors had noticed that some of the texts of these guidelines might benefi t from additional guidance, with a special focus on light of the above, the Expert Committee recommended that the WHO Secretariat initiate the process of developing a new text on good practices for pharmaceutical microbiology following text is proposed to cover this specifi c type of and scope of documentGlossary 1.
71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
GOOD PRACTICES FOR PHARMACEUTICAL, Good practices for pharmaceutical microbiology laboratories, SCHEDULE M, GOOD, PRACTICES, FOR PHARMACEUTICAL, 1117> MICROBIOLOGICAL BEST LABORATORY, 1117〉 Microbiological Best Laboratory Practices, Baird Parker Agar Base, Laboratories, Fluid Thioglycollate medium Thioglycollate, Fluid Thioglycollate medium Thioglycollate medium Fluid